Metabolic Panel

A self-pay metabolic panel at the Zlín poliklinika collection point. The 'Metabolický soubor' measures electrolytes (sodium, potassium, chloride), glucose, kidney markers (urea, creatinine) and albumin for a baseline check of fluid balance and kidney function. A broader 13-analyte admission panel is available. No referral required; payment at the draw.

IFCOR's Liver Function Panel measures nine markers — total protein, albumin, bilirubin (total and conjugated), AST, ALT, GGT, ALP, and cholinesterase — to assess hepatocellular integrity, biliary flow, and the liver's synthetic capacity. Cholinesterase is a marker of hepatic protein synthesis rarely included in standard liver panels; it falls in liver failure, chronic hepatitis, and malnutrition, providing an early synthetic function warning. At 250 Kč total with phlebotomy, this targeted panel is economical enough for repeat monitoring before and after dietary changes, alcohol reduction programmes, or medication adjustments.

IFCOR's Kidney Function Panel tests ten markers covering glomerular filtration, electrolyte balance, tubular function, and urine sediment to give a complete picture of kidney health in a single fasting collection. The CKD-EPI equation — calculated from creatinine, age, and sex — provides an estimated glomerular filtration rate (eGFR) that is the internationally standard metric for chronic kidney disease staging. Uric acid flags gout risk and urate nephropathy. Urinalysis with sediment detects protein loss, blood, and infection indicators that blood tests alone cannot reveal. At 300 Kč, this targeted panel is accessible for regular monitoring in hypertensive, diabetic, or at-risk patients.

IFCOR's Diabetes Screening panel pairs fasting glucose with HbA1c (glycated haemoglobin) — the two-marker combination recommended by international diabetes guidelines for both screening and monitoring. Fasting glucose captures the immediate blood sugar level at the moment of collection; HbA1c reflects average blood glucose over the preceding 8–12 weeks by measuring the percentage of haemoglobin molecules that have been irreversibly glycated. Together they detect pre-diabetes and diabetes more reliably than either marker alone. The panel costs 300 Kč and is suitable for anyone with diabetes risk factors — obesity, family history, gestational diabetes history, hypertension, or fatigue — who wants to check before requesting a full GP work-up.

The metabolic health panel at Laboratoře Mikrochem is a comprehensive biochemistry screen covering 15 or more markers across the four key metabolic systems: glucose and diabetes status (glucose + HbA1c), liver health (ALT, AST, GGT, alkaline phosphatase, bilirubin), kidney function (urea, creatinine, eGFR), and electrolyte balance (sodium, potassium, chloride, calcium). Uric acid is included for gout and metabolic syndrome assessment. All markers are processed on automated photometric biochemistry analysers under ISO 15189 accreditation at the main Olomouc laboratory, with results available within 2 working days. The panel provides a snapshot of metabolic health for annual screening or for monitoring patients on long-term medications. No physician referral is required; fasting (8 hours) is recommended for accurate glucose values.

The Healthy Heart panel at IFCOR goes beyond the standard lipid check by adding two cardiac-specific biomarkers: Troponin I and NT-proBNP. Troponin I is a protein released from heart muscle when cardiac cells are damaged or stressed — elevated levels indicate myocardial injury and are the gold-standard marker for myocardial infarction diagnosis in hospitals. NT-proBNP is a hormone secreted by heart muscle cells under mechanical stretch or volume overload; elevated NT-proBNP is the most sensitive blood marker for heart failure, used internationally for diagnosis, prognosis, and treatment monitoring. Together with the lipid panel and glucose, this combination provides a cardiovascular health picture that goes significantly beyond what a standard annual blood test offers. It is designed for monitoring — not for acute chest pain, which requires emergency medical attention.

EliteMedical's Liver and Kidneys Package detects early dysfunction in the two most metabolically active filter organs — before symptoms develop. The package integrates a targeted internal examination, a blood panel covering liver enzymes (ALT, AST, GGT, bilirubin, albumin), kidney function markers (creatinine, urea, cystatin C, eGFR), and a comprehensive abdominal ultrasound that images the liver, biliary system, and kidneys in real time. Non-alcoholic fatty liver disease (NAFLD) affects an estimated 20–25% of European adults but is often silent until late-stage fibrosis; early detection through enzyme assessment and ultrasound allows dietary and pharmacological intervention before irreversible scarring occurs. Symptoms that may prompt this package include persistent fatigue, nausea, upper abdominal discomfort, dark urine, skin or eye yellowing, or ankle swelling — though many patients with early-stage disease are entirely asymptomatic.